Dr Evan Courville, MD | |
Msc10 5615, 1 University Of New Mexico, Albuquerque, NM 87131 | |
(505) 272-3401 | |
Not Available |
Full Name | Dr Evan Courville |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | Msc10 5615, Albuquerque, New Mexico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376118224 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 326641 (Louisiana) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Evan Courville, MD 114 Windberg Ln, Lafayette, LA 70503-5600 Ph: (337) 349-3707 | Dr Evan Courville, MD Msc10 5615, 1 University Of New Mexico, Albuquerque, NM 87131 Ph: (505) 272-3401 |
News Archive
Prostate cancer is the most common cancer in men. Despite many advances in diagnosis and treatment over the past two decades, it remains the second most common cause of cancer related death in men.
Research led by Christiana Care Health System's Andrew Doorey, M.D. has found that a small number of patients mistakenly undergo bypass surgery after diagnostic angiography.
Working with parents and schools to provide a bug busting approach to head lice is helping to reduce infestation levels, tackle health inequalities and reduce healthcare costs, according to a review in the October issue of Journal of Clinical Nursing.
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
Aetna announced today results of an analysis from the first half of 2009, demonstrating an average medication adherence of over 95 percent for its members taking Specialty medications. Disease states evaluated in Aetna's analysis include: multiple sclerosis, rheumatoid arthritis, HIV, Crohn's disease, Pulmonary Arterial Hypertension (PAH), psoriasis, Hepatitis C and asthma.
› Verified 3 days ago